VISID Eligibility

VISID is recruiting the following groups:

  • People aged 12 years and older who have primary immunodeficiency (inborn error of immunity) or have been on immunotherapy such as rituximab, ocrelizumab for medical conditions AND:
    1. plan to be vaccinated against COVID-19, or
    2. have received their first dose of the COVID-19 Pfizer/BioNTech or Moderna mRNA vaccination, or Astrazeneca, or
    3. were fully vaccinated against COVID-19 less than 24 weeks ago
  • Anyone aged 12 years and older who has not been vaccinated but is planning to be vaccinated against COVID-19

Please select which of the following apply to you:

If you do not meet these criteria but still strongly wish to participate, or have questions about your eligibility, please email the study coordinator at

It does not appear that you are eligible to participate in this study. If you believe you are eligible to participate, please contact our research coordinator at